Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Tobias R. Overbeck"'
Autor:
Armando Santoro, Garrido Pilar, Daniel S.W. Tan, Jon Zugazagoitia, Frances A. Shepherd, Alessandra Bearz, Fabrice Barlesi, Tae Min Kim, Tobias R. Overbeck, Enriqueta Felip, Can Cai, Simantini Eddy, Tracey McCulloch, Eric S. Schaefer
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Despite promising outcomes of treatment with anti-programmed cell death (PD)-1/PD-ligand (L)1 agents in combination with platinum-doublet chemotherapy (PDC) in the first-line setting, a significant unmet medical need remains in pa
Externí odkaz:
https://doaj.org/article/49d4a4474e494f5081ff231d7fc7b4f8
Autor:
Armando Santoro, Garrido Pilar, Daniel S.W. Tan, Jon Zugazagoitia, Frances A. Shepherd, Alessandra Bearz, Fabrice Barlesi, Tae Min Kim, Tobias R. Overbeck, Enriqueta Felip, Can Cai, Simantini Eddy, Tracey McCulloch, Eric S. Schaefer
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/7ffe7831669f4ee5abb317e48ceb96ea
Autor:
Ruben Evertz, Christine Diehl, Katharina Gödde, Miroslava Valentova, Tania Garfias-Veitl, Tobias R. Overbeck, Friederike Braulke, Alessia Lena, Sara Hadzibegovic, Annalen Bleckmann, Ulrich Keller, Ulf Landmesser, Alexander O. König, Gerd Hasenfuss, Andreas Schuster, Markus S. Anker, Stephan von Haehling
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Maintaining cancer patients’ exercise capacity and therefore patients’ ability to live a self-determined life is of huge importance, but little is known about major determinants. We sought to identify determinants of exercise capacity in
Externí odkaz:
https://doaj.org/article/714f73e5313b4f03983b1731284c9e65
Autor:
Dominik Schröder, Christina Müllenmeister, Stephanie Heinemann, Eva Hummers, Frank Klawonn, Kai Vahldiek, Alexandra Dopfer-Jablonka, Sandra Steffens, Marie Mikuteit, Jacqueline Niewolik, Tobias R. Overbeck, Jonathan Kallusky, Gloria Königs, Gloria Heesen, Tim Schmachtenberg, Frank Müller
Publikováno v:
Health Psychology and Behavioral Medicine, Vol 11, Iss 1 (2023)
ABSTRACTObjective The COVID-19 pandemic has affected how people go about their daily lives, often in various and substantial ways. This study aims to prospectively evaluate the changes in social participation during the COVID-19 pandemic in persons w
Externí odkaz:
https://doaj.org/article/e2944800f342472a9ce6ce1223ba3c7a
Autor:
Ruben Evertz, Katharina Gödde, Christine Diehl, Miroslava Valentova, Tania Garfias‐Veitl, Friederike Braulke, Gerald G. Wulf, Tobias R. Overbeck, Annalen Bleckmann, Alexander O. König, Pia Weinländer, Sophia Potthoff, Sara Hadzibegovic, Alessia Lena, Ulrich Keller, Ulf Landmesser, Andreas Schuster, Markus S. Anker, Gerd Hasenfuß, Stephan vonHaehling
Publikováno v:
ESC Heart Failure, Vol 10, Iss 1, Pp 167-176 (2023)
Abstract Aims Maintaining quality of life (QoL) in patients with cancer has gathered significant interest, but little is known about its major determinants. We sought to identify determinants of QoL in patients undergoing cancer treatment as well as
Externí odkaz:
https://doaj.org/article/586093e844e2498bae29c65f7e2a7ebf
Autor:
Julia Felicitas Leni Koenig, Thomas Asendorf, Alfred Simon, Annalen Bleckmann, Lorenz Truemper, Gerald Wulf, Tobias R. Overbeck
Publikováno v:
BMC Palliative Care, Vol 21, Iss 1, Pp 1-10 (2022)
Abstract Background The advance directive represents patients’ health care choices and fosters patients’ autonomy. Nevertheless, understanding patients’ wishes based on the information provided in advance directives remains a challenge for heal
Externí odkaz:
https://doaj.org/article/8ded9082ab8e4d5c8e4a73f1aae9c206
Autor:
Friederike Braulke, Kathrin Kober, Andreas Arndt, Maximilian Papendick, Arne Strauss, Christof Maria Kramm, Kai-Martin Thoms, Alexander König, Jochen Gaedcke, Julia Gallwas, Svenja Wulf, Christoph Szuszies, Gerald Wulf, Ralph Rödel, Susanne Wolfer, Vesna Malinova, Tobias R. Overbeck, Marc Hinterthaner, Joachim Lotz, Friedemann Nauck, Marielle Ernst, Christine Stadelmann, Philipp Ströbel, Volker Ellenrieder, Thomas Asendorf, Stefan Rieken
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionMulti-professional interdisciplinary tumor boards (ITB) are essential institutions to discuss all newly diagnosed, relapsed or complex cancer patients in a team of specialists to find an optimal cancer care plan for each individual patien
Externí odkaz:
https://doaj.org/article/d89f4a014aa445bd8cdf487b1b57a9f6
Autor:
Alexandra Dopfer-Jablonka, Sandra Steffens, Frank Müller, Marie Mikuteit, Jacqueline Niewolik, Anne Cossmann, Metodi V. Stankov, Georg M. N. Behrens, Eva Hummers, Gloria Heesen, Dominik Schröder, Sascha Roder, Frank Klawonn, Kai Vahldiek, Justin Hasenkamp, Jonathan Kallusky, Christine S. Falk, Tobias R. Overbeck, Stephanie Heinemann
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Immunocompromised people (ICP) and elderly individuals (older than 80 years) are at increased risk for severe coronavirus infections. To protect against serious infection with SARS-CoV-2, ICP are taking precautions that may includ
Externí odkaz:
https://doaj.org/article/29e8ea9c8af64537872d10a5de524008
Autor:
Dominik Schröder, Gloria Heesen, Stephanie Heinemann, Eva Hummers, Alexandra Jablonka, Sandra Steffens, Marie Mikuteit, Jacqueline Niewolik, Tobias R. Overbeck, Jonathan Kallusky, Frank Müller
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
Background:Restrictions to contain the COVID-19 pandemic affect the social participation of people worldwide. Especially those at high risk for a severe disease tend to abstain from social gatherings. While there are a few questionnaires to measure s
Externí odkaz:
https://doaj.org/article/2ec8e4c4522d4436ac41122bd65316c3
Autor:
Tobias R. Overbeck, Katja Schmitz, Christoph Engelke, Carsten-Oliver Sahlmann, Sara Hugo, Laura Kellner, Lorenz Trümper, Hans-Ulrich Schildhaus
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 1, Pp 158-163 (2016)
We report on a 90-year-old male patient with a ROS1-translocated adenocarcinoma of the lung who was treated with crizotinib as first-line therapy. After 11 months of treatment, we noticed complete metabolic response as measured by 18F-FDG-PET/CT scan
Externí odkaz:
https://doaj.org/article/a3950f9e2e364b7fab9b32e8831a87e6